Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the need for a multidisciplinary approach to translate the study's findings into real-world ...

Missteps, Equipment Problems and a Common but Risky Practice Led to a Fatal Crash New details revealed by The Times show the complex failures on Jan. 29 before an Army helicopter crashed into a je ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...